Literature DB >> 24167769

Treatment of overactive bladder syndrome with urethral calibration in women.

Chao H Chen1, Renee L Sato, Grace Hk Matsuura, David C Wei, John J Chen.   

Abstract

Our objective was to determine whether urethral calibration with Walther's urethral sounds may be an effective treatment for overactive bladder syndrome. The diagnosis of overactive bladder syndrome is a clinical one based on the presence of urgency, with or without urge incontinence, and is usually accompanied by frequency and nocturia in the absence of obvious pathologic or metabolic disease. These symptoms exert a profound effect on the quality of life. Pharmacologic treatment is generally used to relieve symptoms, however anticholinergic medications may be associated with several undesirable side effects. There are case reports of symptom relief following a relatively quick and simple office procedure known as urethral dilation. It is hypothesized that this may be an effective treatment for the symptoms of overactive bladder. Women with clinical symptoms of overactive bladder were evaluated. Eighty-eight women were randomized to either urethral calibration (Treatment), or placebo (Control) treatment. Women's clinical outcomes at two and eight weeks were assessed and compared between the two treatment arms. Eight weeks after treatment, 31.1% (n=14) of women who underwent urethral calibration were responsive to the treatment versus 9.3% (n=4) of the Control group. Also, 51.1% (n=23) of women within the Treatment group showed at least a partial response versus 20.9% (n=9) of the Control group. Our conclusion is that Urethral calibration significantly improves the symptoms of overactive bladder when compared to placebo and may be an effective alternative treatment method.

Entities:  

Keywords:  Overactive bladder; dilation; urinary incontinence

Mesh:

Year:  2013        PMID: 24167769      PMCID: PMC3796784     

Source DB:  PubMed          Journal:  Hawaii J Med Public Health        ISSN: 2165-8242


  15 in total

Review 1.  Urinary incontinence in the elderly.

Authors:  I Merkelj
Journal:  South Med J       Date:  2001-10       Impact factor: 0.954

Review 2.  Pathophysiology of the overactive bladder.

Authors:  Roger P Goldberg; Peter K Sand
Journal:  Clin Obstet Gynecol       Date:  2002-03       Impact factor: 2.190

3.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

4.  The treatment of sphincter strictures.

Authors:  A R Mundy
Journal:  Br J Urol       Date:  1989-12

5.  How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study.

Authors:  I Milsom; P Abrams; L Cardozo; R G Roberts; J Thüroff; A J Wein
Journal:  BJU Int       Date:  2001-06       Impact factor: 5.588

6.  Urethral syndrome. A comparison of different treatment modalities.

Authors:  A Bergman; M Karram; N N Bhatia
Journal:  J Reprod Med       Date:  1989-02       Impact factor: 0.142

7.  The practice of urethral dilation for voiding dysfunction among fellows of the Section on Urology of the American Academy of Pediatrics.

Authors:  Adam R Metwalli; Earl Y Cheng; Bradley P Kropp; John C Pope
Journal:  J Urol       Date:  2002-10       Impact factor: 7.450

Review 8.  Mechanisms involved in new therapies for overactive bladder.

Authors:  Francisco Cruz
Journal:  Urology       Date:  2004-03       Impact factor: 2.649

Review 9.  Current and future pharmacological treatment for overactive bladder.

Authors:  Naoki Yoshimura; Michael B Chancellor
Journal:  J Urol       Date:  2002-11       Impact factor: 7.450

10.  Short term complications of the tension free vaginal tape operation for stress urinary incontinence in women.

Authors:  Gunilla Bodelsson; Lars Henriksson; Stellan Osser; Martin Stjernquist
Journal:  BJOG       Date:  2002-05       Impact factor: 6.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.